Filing Details
AbbVie Inc. (NYSE:ABBV) filed a Form 8-K with the Securities and Exchange Commission on July 31, 2026, disclosing a material event.
8k filedNYSE:ABBV
AbbVie Inc. (ABBV) Reports Material Event to SEC
Filing Details AbbVie Inc. (NYSE:ABBV) filed a Form 8-K with the Securities and Exchange Commission on July 31, 2026, disclosing a material event. Market Context AbbVie Inc.'s…
Market Context
AbbVie Inc.'s stock currently trades at $250.88 with a market capitalization of $410.1B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for AbbVie Inc.'s stock.
All SEC filings for AbbVie Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ABBV Stock Page
Frequently Asked Questions
Where can I read ABBV's SEC filings?
Browse all filings on our ABBV SEC filings page.
What types of SEC filings does AbbVie Inc. file?
Public companies like AbbVie Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.